Cohort’s (CHRT) Buy Rating Reiterated at Shore Capital

Shore Capital reissued their buy rating on shares of Cohort (LON:CHRTFree Report) in a research note issued to investors on Thursday, MarketBeat.com reports.

Cohort Stock Down 1.0 %

Shares of LON CHRT opened at GBX 830 ($10.55) on Thursday. Cohort has a 52-week low of GBX 430 ($5.47) and a 52-week high of GBX 848 ($10.78). The business’s 50 day moving average is GBX 740.56 and its two-hundred day moving average is GBX 611.64. The company has a quick ratio of 0.93, a current ratio of 1.69 and a debt-to-equity ratio of 32.14. The firm has a market cap of £337.48 million, a price-to-earnings ratio of 2,515.15 and a beta of 0.51.

Insider Transactions at Cohort

In other news, insider Andrew Stephen Thomis sold 2,944 shares of the company’s stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of GBX 680 ($8.64), for a total transaction of £20,019.20 ($25,443.82). In related news, insider Simon Walther sold 803 shares of the business’s stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of GBX 749 ($9.52), for a total transaction of £6,014.47 ($7,644.22). Also, insider Andrew Stephen Thomis sold 2,944 shares of the business’s stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of GBX 680 ($8.64), for a total transaction of £20,019.20 ($25,443.82). Corporate insiders own 34.89% of the company’s stock.

Cohort Company Profile

(Get Free Report)

Cohort plc, through its subsidiaries, provides various products and services in defense, security, and related markets in the United Kingdom, Germany, Portugal, Africa, North and South America, and the Asia Pacific and Africa. The company offers electro-optical and electro-mechanical systems, such as command, control, communications, computers, intelligence, surveillance, target acquisition, and reconnaissance, as well as combat systems; and communications systems.

Read More

Receive News & Ratings for Cohort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cohort and related companies with MarketBeat.com's FREE daily email newsletter.